Munich, Germany \u2014 Micro\u00adPort Scien\u00adti\u00adfic Corpo\u00adra\u00adtion, through its subsi\u00addiary Micro\u00adPort Surgi\u00adcal B.V., has acqui\u00adred 100% of the shares in Hemo\u00advent GmbH for a purchase price of up to EUR 123 million.<\/p>\n
Foun\u00added in 2013 in Aachen, Germany, Hemo\u00advent is a medi\u00adcal device company specia\u00adli\u00adzing in the deve\u00adlo\u00adp\u00adment of breakth\u00adrough extra\u00adcor\u00adpo\u00adreal life support (ECLS) systems. Hemo\u00adven\u00adt\u2019s flag\u00adship MOBYBOX\u00ae system is the first fully inte\u00adgra\u00adted ECLS system that controls both perfu\u00adsion and gas exch\u00adange in a single device, setting a new stan\u00addard for ECMO devices in terms of mobi\u00adlity and ease of use.
\nMicro\u00adPort\u00ae has estab\u00adlished itself in the criti\u00adcal care field through its subsi\u00addiary Micro\u00adPort\u00ae Surgery, which is commit\u00adted to provi\u00adding pati\u00adents with compre\u00adhen\u00adsive medi\u00adcal solu\u00adti\u00adons for cardiac surgery, emer\u00adgency medi\u00adcine and criti\u00adcal care. The acqui\u00adsi\u00adtion of Hemo\u00advent will further advance MicroPort\u00ae\u2018s emer\u00adgency and criti\u00adcal care stra\u00adtegy by combi\u00adning cardio\u00adpul\u00admo\u00adnary bypass (CPB) with rese\u00adarch and deve\u00adlo\u00adp\u00adment, manu\u00adfac\u00adtu\u00adring and marke\u00adting of ECMO products.<\/p>\n
Legal advi\u00adsor to the share\u00adhol\u00adders of Hemo\u00advent GmbH: LUTZ | ABEL Rechts\u00adan\u00adwalts PartG mbB<\/strong> Legal advi\u00adsors Micro\u00adPort Surgi\u00adcal B.V.: Fresh\u00adfields Bruck\u00adhaus Derin\u00adger (Frank\u00adfurt a. Main \/ Hamburg)<\/strong> About LUTZ | ABEL<\/strong><\/p>\n With around 85 lawy\u00aders and offices in Munich, Hamburg, Stutt\u00adgart and Berlin, the commer\u00adcial law firm LUTZ | ABEL provi\u00addes advice on all aspects of commer\u00adcial law.<\/p>\n","protected":false},"excerpt":{"rendered":" Munich, Germany \u2014 Micro\u00adPort Scien\u00adti\u00adfic Corpo\u00adra\u00adtion, through its subsi\u00addiary Micro\u00adPort Surgi\u00adcal B.V., has acqui\u00adred 100% of the shares in Hemo\u00advent GmbH for a purchase price of up to EUR 123 million. Foun\u00added in 2013 in Aachen, Germany, Hemo\u00advent is a medi\u00adcal device company specia\u00adli\u00adzing in the deve\u00adlo\u00adp\u00adment of breakth\u00adrough extra\u00adcor\u00adpo\u00adreal life support (ECLS) systems. Hemo\u00adven\u00adt\u2019s [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":38188,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366,1367,1368],"tags":[],"class_list":["post-40259","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","category-lawyers-tax-advisors-auditors-en","category-lawyers-tax-consultants-auditors"],"yoast_head":"\n
\nThe advi\u00adsory team around Dr. Bern\u00adhard Noreisch (photo<\/strong>), Part\u00adner (lead, Munich) included Dr. Corne\u00adlius Renner (IP, Berlin), Frank Hahn (M&A, Hamburg) and Jan-Phil\u00adlip Kunz (VC\/M&A, Munich).<\/p>\n
\nM&A Advi\u00adsor: William Blair, London<\/p>\n